Genotype and risk of major bleeding during warfarin treatment

AIM: To determine whether genetic variants associated with warfarin dose variability were associated with increased risk of major bleeding during warfarin therapy. MATERIALS & METHODS: Using Vanderbilt’s DNA biobank we compared the prevalence of CYP2C9, VKORC1 and CYP4F2 variants in 250 cases wi...

詳細記述

保存先:
書誌詳細
出版年:Pharmacogenomics
主要な著者: Kawai, Vivian K, Cunningham, Andrew, Vear, Susan I, Van Driest, Sara L, Oginni, Abimbola, Xu, Hua, Jiang, Min, Li, Chun, Denny, Joshua C, Shaffer, Christian, Bowton, Erica, Gage, Brian F, Ray, Wayne A, Roden, Dan M, Stein, C Michael
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4304738/
https://ncbi.nlm.nih.gov/pubmed/25521356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.14.153
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料